您当前的位置：
首页 >
文章列表页 >
Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
更新时间：2023-08-29

    • Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer

    • Genes & Diseases   Vol. 10, Issue 1, (2023)
    • 作者机构：

      1. Key Laboratory of Gynecologic Oncology of Shandong Province, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University,Shandong,Jinan,China,250012

      2. Department of Clinical Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University,Shandong,Jinan,China,250021

      3. Department of Clinical Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong University,Shandong,Jinan,China,250021

      4. Department of Obstetrics and Gynecology, The Fifth People's Hospital of Jinan,Shandong,Jinan,China,250022

      5. Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University,Shandong,Jinan,China,250012

      6. Shandong Engineering Laboratory for Urogynecology, Qilu Hospital of Shandong University,Shandong,Jinan,China,250012

    • DOI：10.1016/j.gendis.2021.12.018    

      CLC：

    • Published：2023，

      Published Online：1 January 2023，

    扫 描 看 全 文

  • Rui Xu, Hui Peng, Ning Yang, et al. Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer. [J]. Genes & Diseases 10(1).(2023) DOI： 10.1016/j.gendis.2021.12.018.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0